Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CB-012
i
Other names:
CB-012, anti-CD371 scFvs
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Caribou Biosci
Drug class:
CLL-1-targeted CAR-T immunotherapy
Related drugs:
‹
CD371-YSNVZ-IL18 CAR T cells (0)
CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells (0)
CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T (0)
CLL1+CD33 CAR-T (0)
Dual CD33/CLL1 CAR T (0)
KITE-222 (0)
Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells (0)
CD371-YSNVZ-IL18 CAR T cells (0)
CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells (0)
CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T (0)
CLL1+CD33 CAR-T (0)
Dual CD33/CLL1 CAR T (0)
KITE-222 (0)
Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login